Prime editing overcomes histone gene redundancy, revealing a functional map of chromatin regulation in mammals
Background
The genome, the blueprint of life, relies on histones, proteins that package DNA, to perform its functions. Cells fine-tune gene expression by applying post-translational modifications (PTMs) such as methylation or acetylation to histone proteins. These modifications act as molecular switches, determining when and how strongly a specific gene is activated. Researchers have typically used an approach of substituting amino acid residues and analyzing cellular changes to elucidate the function of specific PTMs.
However, research on editing histone regions in mammalian cells has faced challenges. Unlike other proteins, histones have multiple copies of the same gene distributed throughout the genome. Existing gene editing technologies have made it nearly impossible to correct all these copies simultaneously. This has limited mammalian histone research to model organisms with simpler genomes, such as yeast and fruit flies.
Key Findings
The researchers developed a high-throughput CRISPR prime editing platform that precisely edits both canonical and noncanonical histone H3 genes in mammals while maintaining the genomic structure. This platform allows for the reversible and combinatorial modification of individual histone genes. The researchers performed experiments by substituting lysine residues with arginine, using synonymous control groups as a reference.
The experiments identified key lysine residues that affect the growth of mouse embryonic stem cells (mESCs). Mutations in H3K4, H3K9, H3K14, H3K18, and H3K79 residues significantly reduce the fitness of stem cells. In particular, the study confirmed that the H3K56 residue, known to contribute to genome stability in yeast and fruit flies, performs the same function in mammalian cells, demonstrating its evolutionary conservation.
Furthermore, the researchers elucidated the interactions between histone residues through double-mutant analysis. For example, the simultaneous occurrence of H3K27R and H3K36R mutations was found to inhibit the self-renewal ability of stem cells and broadly alter gene transcription patterns. This directly demonstrates the complex mechanism of action of multiple histone mutations at the molecular level, which cannot be explained by single mutations alone.
Significance and Prospects
This study is the first to complete a functional map of histone H3 lysine residues in mammals, opening a new chapter in chromatin regulation research. The CRISPR prime editing platform, which overcomes the genetic redundancy of histones, is expected to be widely used in future genome regulation research and drug target discovery. In particular, research on epigenetic diseases such as cancer is expected to benefit.
However, this study is limited by its focus on mouse embryonic stem cell models. Follow-up studies are needed to verify whether the same mechanism functions in human cells or differentiated tissues. Analyzing the mutations and multidimensional interactions of other amino acid residues besides lysine to unravel complex epigenetic codes remains a future challenge.
Histone post-translational modifications are fundamental to genome regulation, yet dissecting the functions of individual histone marks in mammals remains challenging due to the presence of multiple histone gene copies. Here we develop a high-throughput clustered regularly interspaced short palindromic repeats (CRISPR) prime editing platform enabling precise, reversible and combinatorial mutagenesis of canonical and noncanonical histone H3 genes within their native genomic context. Using systematic lysine-to-arginine substitutions benchmarked against synonymous controls, we identify key residues, including H3K4, H3K9, H3K14, H3K18 and H3K79, whose mutation compromises fitness in mouse embryonic stem cells. We further show that H3K56, linked to genome stability in yeast and Drosophila, has a conserved role in mammalian cells. Through analysis of selected double mutants, we uncover functional crosstalk across residues, with combinations such as H3K27R + H3K36R impairing stem cell self-renewal and altering transcription. Altogether, this study establishes a functional map of histone H3 lysines in mammals and provides a broadly applicable platform for systematic dissection of chromatin regulation.
This histone editing technology is considered a key tool that will accelerate the development of epigenetically-based new drugs. In the past, when verifying the efficacy of specific histone-targeting drugs, researchers relied on indirect chemical treatments, making it difficult to predict side effects. However, by using a precise lysine substitution platform, the efficacy and toxicity of drugs that block only specific histone PTMs can be clearly compared at the genome level.
It also provides valuable insights for designing personalized therapies for rare cancers caused by specific histone mutations, such as pediatric brain tumors. In this scenario, the patient's mutation pattern is replicated in mouse embryonic stem cells or human induced pluripotent stem cells for screening. By controlling the action pathway of the H3K27R and H3K36R combinations, which regulate the self-renewal and differentiation of stem cells, it may be possible to increase the efficiency of large-scale production of stem cell therapeutic agents in the field of regenerative medicine.